Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome
- PMID: 19118007
- PMCID: PMC2744125
- DOI: 10.1158/0008-5472.CAN-08-2586
Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome
Abstract
Mechanisms of action of nonmutagenic carcinogens such as asbestos remain poorly characterized. As pleural mesothelioma is known to have limited numbers of genetic mutations, we aimed to characterize the relationships among gene-locus-specific methylation alterations, disease status, asbestos burden, and survival in this rapidly fatal asbestos-associated tumor. Methylation of 1505 CpG loci associated with 803 cancer-related genes were studied in 158 pleural mesotheliomas and 18 normal pleura. After false-discovery rate correction, 969 CpG loci were independently associated with disease status (Q < 0.05). Classifying samples based on CpG methylation profile with a mixture model approach, methylation classes discriminated tumor from normal pleura (permutation P < 0.0001). In a random forests classification, the overall misclassification error rate was 3.4%, with <1% (n = 1) of tumors misclassified as normal (P < 0.0001). Among tumors, methylation class membership was significantly associated with lung tissue asbestos body burden (P < 0.03), and significantly predicted survival (likelihood ratio P < 0.01). Consistent with prior work, asbestos burden was associated with an increased risk of death (hazard ratio, 1.4; 95% confidence interval, 1.1-1.8). Our results have shown that methylation profiles powerfully differentiate diseased pleura from nontumor pleura and that asbestos burden and methylation profiles are independent predictors of mesothelioma patient survival. We have added to the growing body of evidence that cellular epigenetic dysregulation is a critical mode of action for asbestos in the induction of pleural mesothelioma. Importantly, these findings hold great promise for using epigenetic profiling in the diagnosis and prognosis of human cancers.
Figures



Similar articles
-
Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles.Cancer Res. 2009 Aug 1;69(15):6315-21. doi: 10.1158/0008-5472.CAN-09-1073. Epub 2009 Jul 28. Cancer Res. 2009. PMID: 19638575 Free PMC article.
-
Genome-wide DNA methylation analysis reveals a unique methylation pattern for pleural mesothelioma compared to healthy pleura and other lung diseases.Clin Epigenetics. 2024 Dec 3;16(1):176. doi: 10.1186/s13148-024-01790-z. Clin Epigenetics. 2024. PMID: 39627815 Free PMC article.
-
[Pulmonary concentration of asbestos fibers in steel workers with pleural mesothelioma].G Ital Med Lav Ergon. 2010 Apr-Jun;32(2):149-53. G Ital Med Lav Ergon. 2010. PMID: 20684435 Italian.
-
The role of epigenetics in malignant pleural mesothelioma.Lung Cancer. 2013 Sep;81(3):311-318. doi: 10.1016/j.lungcan.2013.05.014. Epub 2013 Jun 18. Lung Cancer. 2013. PMID: 23790315 Review.
-
Familial mesothelioma of the pleura--a report of 40 cases.Ind Health. 2004 Apr;42(2):235-9. doi: 10.2486/indhealth.42.235. Ind Health. 2004. PMID: 15128174 Review.
Cited by
-
CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure.BMC Cancer. 2019 May 28;19(1):507. doi: 10.1186/s12885-019-5652-y. BMC Cancer. 2019. PMID: 31138176 Free PMC article.
-
MiR-21 over-expression and Programmed Cell Death 4 down-regulation features malignant pleural mesothelioma.Oncotarget. 2018 Apr 3;9(25):17300-17308. doi: 10.18632/oncotarget.24644. eCollection 2018 Apr 3. Oncotarget. 2018. PMID: 29707109 Free PMC article.
-
Recursively partitioned mixture model clustering of DNA methylation data using biologically informed correlation structures.Stat Appl Genet Mol Biol. 2013 Mar 5;12(2):225-40. doi: 10.1515/sagmb-2012-0068. Stat Appl Genet Mol Biol. 2013. PMID: 23468465 Free PMC article.
-
Genomics and Functional Genomics of Malignant Pleural Mesothelioma.Int J Mol Sci. 2020 Sep 1;21(17):6342. doi: 10.3390/ijms21176342. Int J Mol Sci. 2020. PMID: 32882916 Free PMC article. Review.
-
DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma.J Natl Cancer Inst. 2011 Jan 19;103(2):143-53. doi: 10.1093/jnci/djq497. Epub 2010 Dec 16. J Natl Cancer Inst. 2011. PMID: 21163902 Free PMC article.
References
-
- Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–767. - PubMed
-
- Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer. 1991;51:3075–3079. - PubMed
-
- Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nature reviews. 2002;3:415–428. - PubMed
-
- Robinson BW, Lake RA. Advances in malignant mesothelioma. The New England journal of medicine. 2005;353:1591–1603. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials